Scarica l'app Stockscreener
74.93
2.08%
1.53
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché HALO Giù?
Forum
Previsione
Halozyme Therapeutics Inc Borsa (HALO) Ultime notizie
Halozyme Therapeutics Inc. stock prediction for this weekWeekly Trade Summary & Real-Time Buy Signal Notifications - Newser
RYBREVANT®▼ (amivantamab) plus LAZCLUZE®▼ (lazertinib) reduces acquired resistance versus osimertinib in first-line EGFR-mutated advanced non-small cell lung cancer - GlobeNewswire Inc.
What drives Halozyme Therapeutics Inc.’s stock priceJuly 2025 Price Swings & Stepwise Trade Signal Guides - خودرو بانک
What to do if you’re stuck in Halozyme Therapeutics Inc.Market Rally & Smart Investment Allocation Tips - Newser
Zacks.com featured highlights include Halozyme Therapeutics, Phibro, Leidos and PDD Holdings - Yahoo Finance
Bet on These 3 Stocks With Upgraded Broker Ratings for Robust Returns - Yahoo Finance
Forecasting Halozyme Therapeutics Inc. price range with options dataDividend Hike & Weekly High Return Stock Forecasts - Newser
Is Halozyme Therapeutics Inc. stock entering bullish territory2025 Market WrapUp & Safe Capital Growth Tips - Newser
Halozyme Therapeutics Inc. stock chart pattern explainedLong Setup & Technical Entry and Exit Alerts - Newser
Applying Wyckoff theory to Halozyme Therapeutics Inc. stockMarket Volume Report & Accurate Intraday Trade Tips - Newser
Halozyme Therapeutics Inc. recovery potential after sell off2025 Key Lessons & Weekly Top Stock Performers List - Newser
Halozyme at Wells Fargo Conference: Strategic Growth and Challenges By Investing.com - Investing.com Canada
Halozyme Therapeutics (HALO): Revolutionizing Drug Delivery and Scaling Commercial Success - AInvest
Halozyme Therapeutics Presents at Wells Fargo 20th Annual Healthcare Conference 2025: Q&A Session with Helen Torley - AInvest
Halozyme up after guidance raise, Morgan Stanley upgrade - MSN
Transcript : Halozyme Therapeutics, Inc. Presents at Wells Fargo 20th Annual Healthcare Conference 2025, Sep-04-2025 01 - MarketScreener
4 PEG-Rated GARP Stocks That Offer Both Value and Growth - Zacks Investment Research
Leading vs lagging indicators on Halozyme Therapeutics Inc. performance2025 Earnings Surprises & AI Powered Buy and Sell Recommendations - Newser
Will Halozyme Therapeutics Inc. outperform the marketQuarterly Trade Summary & Free Safe Entry Trade Signal Reports - Newser
What to expect from Halozyme Therapeutics Inc. in the next 30 daysPortfolio Gains Summary & Free Community Supported Trade Ideas - Newser
Halozyme Therapeutics stock reaches all-time high at 74.79 USD By Investing.com - Investing.com Canada
Trend analysis for Halozyme Therapeutics Inc. this weekJuly 2025 Technicals & Safe Capital Growth Plans - Newser
Visual trend scoring systems applied to Halozyme Therapeutics Inc.Weekly Stock Summary & Long-Term Growth Stock Strategies - Newser
Are You Looking for a Top Momentum Pick? Why Halozyme Therapeutics (HALO) is a Great Choice - sharewise.com
Connaughton sells Halozyme Therapeutics (HALO) stock worth $294,736 By Investing.com - Investing.com Australia
Halozyme Therapeutics (HALO)A Momentum Leader with Strong Performance - AInvest
Halozyme Therapeutics stock reaches all-time high at 74.79 USD - Investing.com
Halozyme Therapeutics and atai Life Sciences N.V. Lead Medical Stocks with 53.4% and 245.1% Year-to-Date Returns Respectively. - AInvest
Best Momentum Stock to Buy for September 3rd - TradingView
Are Medical Stocks Lagging Halozyme Therapeutics (HALO) This Year? - Yahoo Finance
How to Find Strong Buy Medical Stocks Using the Zacks Rank - Yahoo Finance
Halozyme Therapeutics, Inc. (HALO) Hit a 52 Week High, Can the Run Continue? - Yahoo Finance
Investors Still Aren't Entirely Convinced By Halozyme Therapeutics, Inc.'s (NASDAQ:HALO) Earnings Despite 26% Price Jump - 富途牛牛
New Strong Buy Stocks for September 3rd - The Globe and Mail
Analyzing net buyer seller activity in Halozyme Therapeutics Inc.2025 Analyst Calls & Low Risk High Reward Ideas - Newser
Published on: 2025-09-03 04:54:32 - Newser
Halozyme Therapeutics Inc. stock volume spike explainedTrade Analysis Report & Fast Gain Stock Trading Tips - Newser
Connaughton sells Halozyme Therapeutics (HALO) stock worth $294,736 - Investing.com
What is Halozyme Therapeutics Inc. s P E ratio telling usJuly 2025 PreEarnings & Short-Term High Return Strategies - خودرو بانک
RSI + MACD Show Convergence for Halozyme Therapeutics Inc.Bull Run & Free Expert Verified Stock Movement Alerts - beatles.ru
Earnings Recap: What is Halozyme Therapeutics Inc.’s book value per share - خودرو بانک
Here's How Much a $1000 Investment in Halozyme Therapeutics Made 10 Years Ago Would Be Worth Today - sharewise.com
Can a trend reversal in Halozyme Therapeutics Inc. lead to recoveryQuarterly Earnings Report & Expert Curated Trade Ideas - Newser
Volatility clustering patterns for Halozyme Therapeutics Inc.July 2025 Weekly Recap & Fast Gain Stock Trading Tips - Newser
What’s next for Halozyme Therapeutics Inc. stock priceJuly 2025 Momentum & Community Supported Trade Ideas - Newser
Published on: 2025-09-01 15:56:05 - Newser
Is Halozyme Therapeutics Inc. stock ready for a breakoutQuarterly Portfolio Review & Entry Point Confirmation Signals - Newser
Live Chart Scan Detects Wedge Pattern in Halozyme Therapeutics Inc. getLinesFromResByArray error: size == 0 - 더경남뉴스
A | Can Halozyme Therapeutics, Inc. outperform under higher oil prices - خودرو بانک
What candlestick patterns are forming on Halozyme Therapeutics Inc.July 2025 Review & Consistent Income Trade Ideas - Newser
Published on: 2025-08-31 22:36:40 - beatles.ru
Trendlines Suggest Halozyme Therapeutics Inc. May Bottom Out SoonQuarterly Market Review & Long Hold Capital Preservation Tips - beatles.ru
Real time social sentiment graph for Halozyme Therapeutics Inc.CEO Change & Long-Term Capital Growth Strategies - Newser
Applying big data sentiment scoring on Halozyme Therapeutics Inc.Bear Alert & Weekly High Potential Stock Alerts - Newser
1.40%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):